Meta AnalysisID 2821

直肠给予吲哚美辛预防中重度ERCP术后胰腺炎和死亡并应在术前使用:一项基于汇总亚组数据的Meta分析

CRD42016038397

The effect of rectal indomethacin in preventing the rate of post-ERCP pancreatitis.

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2821
Evidence Id
11379
Core Evidence Id
11379
Source Meta Analysis Id
2765
Herb2 Meta Analysis Id
HBMA002765
Crd Id
CRD42016038397
Title
Rectal Indomethacin Prevents Moderate to Severe Post- ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data
Review Question
The effect of rectal indomethacin in preventing the rate of post-ERCP pancreatitis.
Study Type Included
Only RCTs were included. No studies were excluded based on the language of publication, quality of study, duration of follow-up, or country of origin.
Condition Being Studied
Post-ERCp pancreatitis
Participant
All adult patients undergoing ERCP.
Animal
Human Disease Modelled
Intervention
We required that patients in the included trial be randomized to rectal indomethacin or placebo prior to or immediately after ERCP.
Comparator Control
Placebo
Main Outcome
The outcome of interest was the incidence of post-ERCP pancreatitis in the 7-day period following ERCP. Measures of effect The main outcome of interest was the incidence of PEP within a 7-day period following the ERCP. Secondary outcomes were set to compare incidence of moderate to severe post-ERCP pancreatitis in the 7-day period following ERCP as well as death.
Outcome Measure
Additional Outcome
Incidence of severe post-ERCP pancreatitis in the 7-day period following ERCP.Incidence of post-ERCP mortality in the 7-day period following ERCP. Measures of effect Subgroup analyses and analyses of aggregate subgroup data were planned beforehand according to different patient characteristics that included high-risk versus average-risk for PEP; sphincter of Oddi dyskinesia; those undergoing pancreatic, biliary, or precut sphincterotomy or prophylactic pancreatic stent placement; and according to differing doses and timing of administration of rectal indomethacin. The analysis was also planned for the rate of moderate to severe pancreatitis and death. We respected authors’ definition of high-risk and average- risk population as mentioned previously.
Study Method
Intervention, Systematic review
Keyword
Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Humans; Indomethacin; Pancreatitis; Precision Medicine
Contact
Dr Yaghoobi [email protected]
Organisational Affiliation
McMaster University mcmaster.ca
Funding Source
Other Selection Criteria
Final Publication
Yaghoobi M, Alzahrani MA, McNabb-Baltar J, Martel M, Barkun AN. Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data. J Can Assoc Gastroenterol. 2018 Mar 27;1(2):67-75. doi: 10.1093/jcag/gwy006. PMID: 31294402; PMCID: PMC6487993. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487993/
Same Topic Review
Yaghoobi M, Rolland S, Waschke KA, McNabb-Baltar J, Martel M, Bijarchi R, Szego P, Barkun AN. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther 2013 Nov;38(9):995-1001
Published Protocol
Review Type
Language
English
Country
Canada
Review Stage
Review Completed not published
First Submission Date
2020-03-31
Registration Date
2016-04-27
Anticipated Start Date
2016-04-01
Anticipated Completion Date
2016-05-31
Title Cn
直肠给予吲哚美辛预防中重度ERCP术后胰腺炎和死亡并应在术前使用:一项基于汇总亚组数据的Meta分析
Title En
Rectal Indomethacin Prevents Moderate to Severe Post- ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data
Bilingual Status
complete